25 XP   0   0   10

IDEXX Laboratories Inc
Buy, Hold or Sell?

Let's analyse Idexx together

PenkeI guess you are interested in IDEXX Laboratories Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of IDEXX Laboratories Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about IDEXX Laboratories Inc

I send you an email if I find something interesting about IDEXX Laboratories Inc.

Quick analysis of Idexx (30 sec.)










What can you expect buying and holding a share of Idexx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
$17.68
Expected worth in 1 year
$59.61
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$41.93
Return On Investment
8.7%

For what price can you sell your share?

Current Price per Share
$480.60
Expected price per share
$435.83 - $543.33
How sure are you?
50%

1. Valuation of Idexx (5 min.)




Live pricePrice per Share (EOD)

$480.60

Intrinsic Value Per Share

$60.29 - $114.75

Total Value Per Share

$77.96 - $132.42

2. Growth of Idexx (5 min.)




Is Idexx growing?

Current yearPrevious yearGrowGrow %
How rich?$1.4b$608.7m$875.7m59.0%

How much money is Idexx making?

Current yearPrevious yearGrowGrow %
Making money$845m$679m$165.9m19.6%
Net Profit Margin23.1%20.2%--

How much money comes from the company's main activities?

3. Financial Health of Idexx (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#22 / 144

Most Revenue
#23 / 144

Most Profit
#14 / 144

What can you expect buying and holding a share of Idexx? (5 min.)

Welcome investor! Idexx's management wants to use your money to grow the business. In return you get a share of Idexx.

What can you expect buying and holding a share of Idexx?

First you should know what it really means to hold a share of Idexx. And how you can make/lose money.

Speculation

The Price per Share of Idexx is $480.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Idexx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Idexx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $17.68. Based on the TTM, the Book Value Change Per Share is $10.48 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.77 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Idexx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps10.062.1%10.062.1%8.031.7%7.661.6%5.181.1%
Usd Book Value Change Per Share10.482.2%10.482.2%-0.77-0.2%3.560.7%1.290.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.310.1%0.150.0%
Usd Total Gains Per Share10.482.2%10.482.2%-0.77-0.2%3.860.8%1.440.3%
Usd Price Per Share555.05-555.05-407.96-476.49-306.33-
Price to Earnings Ratio55.16-55.16-50.82-62.09-57.36-
Price-to-Total Gains Ratio52.95-52.95--526.62-51.56-42.21-
Price to Book Ratio31.40-31.40-56.70-73.55--172.66-
Price-to-Total Gains Ratio52.95-52.95--526.62-51.56-42.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share480.6
Number of shares2
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.31
Usd Book Value Change Per Share10.483.56
Usd Total Gains Per Share10.483.86
Gains per Quarter (2 shares)20.967.73
Gains per Year (2 shares)83.8630.92
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10847422821
2016815855752
3025224278583
4033532610114114
5041941012142145
6050349415171176
7058757817199207
8067166220228238
9075574622256269
10083983025285300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%31.02.00.093.9%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%6.04.00.060.0%22.011.00.066.7%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%3.00.07.030.0%3.00.030.09.1%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%6.04.00.060.0%22.011.00.066.7%

Fundamentals of Idexx

About IDEXX Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Fundamental data was last updated by Penke on 2024-05-02 21:09:08.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of IDEXX Laboratories Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Idexx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 23.1% means that $0.23 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IDEXX Laboratories Inc:

  • The MRQ is 23.1%. The company is making a huge profit. +2
  • The TTM is 23.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ23.1%TTM23.1%0.0%
TTM23.1%YOY20.2%+2.9%
TTM23.1%5Y21.1%+1.9%
5Y21.1%10Y17.3%+3.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ23.1%-7.3%+30.4%
TTM23.1%-6.7%+29.8%
YOY20.2%-1.9%+22.1%
5Y21.1%-1.5%+22.6%
10Y17.3%-3.4%+20.7%
1.1.2. Return on Assets

Shows how efficient Idexx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
  • 25.9% Return on Assets means that Idexx generated $0.26 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IDEXX Laboratories Inc:

  • The MRQ is 25.9%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 25.9%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ25.9%TTM25.9%0.0%
TTM25.9%YOY24.7%+1.2%
TTM25.9%5Y26.0%-0.1%
5Y26.0%10Y21.0%+4.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ25.9%-1.6%+27.5%
TTM25.9%-1.3%+27.2%
YOY24.7%-0.9%+25.6%
5Y26.0%-0.5%+26.5%
10Y21.0%-0.9%+21.9%
1.1.3. Return on Equity

Shows how efficient Idexx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
  • 56.9% Return on Equity means Idexx generated $0.57 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IDEXX Laboratories Inc:

  • The MRQ is 56.9%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 56.9%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ56.9%TTM56.9%0.0%
TTM56.9%YOY111.6%-54.6%
TTM56.9%5Y121.9%-65.0%
5Y121.9%10Y76.4%+45.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ56.9%-0.5%+57.4%
TTM56.9%0.2%+56.7%
YOY111.6%-0.3%+111.9%
5Y121.9%-1.4%+123.3%
10Y76.4%-2.3%+78.7%

1.2. Operating Efficiency of IDEXX Laboratories Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Idexx is operating .

  • Measures how much profit Idexx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
  • An Operating Margin of 30.0% means the company generated $0.30  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IDEXX Laboratories Inc:

  • The MRQ is 30.0%. The company is operating very efficient. +2
  • The TTM is 30.0%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ30.0%TTM30.0%0.0%
TTM30.0%YOY26.7%+3.3%
TTM30.0%5Y26.9%+3.1%
5Y26.9%10Y23.0%+3.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ30.0%-8.8%+38.8%
TTM30.0%0.5%+29.5%
YOY26.7%4.0%+22.7%
5Y26.9%3.7%+23.2%
10Y23.0%-1.3%+24.3%
1.2.2. Operating Ratio

Measures how efficient Idexx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.70 means that the operating costs are $0.70 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of IDEXX Laboratories Inc:

  • The MRQ is 0.700. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.700. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.700TTM0.7000.000
TTM0.700YOY0.733-0.033
TTM0.7005Y0.731-0.031
5Y0.73110Y0.766-0.035
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7001.280-0.580
TTM0.7001.304-0.604
YOY0.7331.240-0.507
5Y0.7311.242-0.511
10Y0.7661.205-0.439

1.3. Liquidity of IDEXX Laboratories Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Idexx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.57 means the company has $1.57 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of IDEXX Laboratories Inc:

  • The MRQ is 1.571. The company is able to pay all its short-term debts. +1
  • The TTM is 1.571. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.571TTM1.5710.000
TTM1.571YOY0.891+0.680
TTM1.5715Y1.295+0.276
5Y1.29510Y1.108+0.187
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5712.111-0.540
TTM1.5712.298-0.727
YOY0.8912.599-1.708
5Y1.2953.012-1.717
10Y1.1083.081-1.973
1.3.2. Quick Ratio

Measures if Idexx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.96 means the company can pay off $0.96 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IDEXX Laboratories Inc:

  • The MRQ is 0.958. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.958. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.958TTM0.9580.000
TTM0.958YOY0.415+0.543
TTM0.9585Y0.754+0.204
5Y0.75410Y0.758-0.004
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9581.230-0.272
TTM0.9581.345-0.387
YOY0.4151.661-1.246
5Y0.7541.957-1.203
10Y0.7582.295-1.537

1.4. Solvency of IDEXX Laboratories Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Idexx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Idexx to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.54 means that Idexx assets are financed with 54.5% credit (debt) and the remaining percentage (100% - 54.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IDEXX Laboratories Inc:

  • The MRQ is 0.545. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.545. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.545TTM0.5450.000
TTM0.545YOY0.778-0.234
TTM0.5455Y0.733-0.189
5Y0.73310Y0.875-0.141
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5450.432+0.113
TTM0.5450.407+0.138
YOY0.7780.394+0.384
5Y0.7330.448+0.285
10Y0.8750.446+0.429
1.4.2. Debt to Equity Ratio

Measures if Idexx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Idexx to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 119.6% means that company has $1.20 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IDEXX Laboratories Inc:

  • The MRQ is 1.196. The company is able to pay all its debts with equity. +1
  • The TTM is 1.196. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.196TTM1.1960.000
TTM1.196YOY3.512-2.316
TTM1.1965Y3.839-2.643
5Y3.83910Y2.997+0.841
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1960.606+0.590
TTM1.1960.571+0.625
YOY3.5120.603+2.909
5Y3.8390.651+3.188
10Y2.9970.739+2.258

2. Market Valuation of IDEXX Laboratories Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Idexx generates.

  • Above 15 is considered overpriced but always compare Idexx to the Diagnostics & Research industry mean.
  • A PE ratio of 55.16 means the investor is paying $55.16 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IDEXX Laboratories Inc:

  • The EOD is 47.761. Based on the earnings, the company is overpriced. -1
  • The MRQ is 55.159. Based on the earnings, the company is expensive. -2
  • The TTM is 55.159. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD47.761MRQ55.159-7.399
MRQ55.159TTM55.1590.000
TTM55.159YOY50.823+4.336
TTM55.1595Y62.095-6.935
5Y62.09510Y57.364+4.730
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD47.761-0.259+48.020
MRQ55.159-0.395+55.554
TTM55.159-0.199+55.358
YOY50.823-0.008+50.831
5Y62.0953.483+58.612
10Y57.3644.434+52.930
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of IDEXX Laboratories Inc:

  • The EOD is 52.220. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 60.310. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 60.310. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD52.220MRQ60.310-8.089
MRQ60.310TTM60.3100.000
TTM60.310YOY87.565-27.255
TTM60.3105Y78.586-18.276
5Y78.58610Y67.615+10.971
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD52.220-0.405+52.625
MRQ60.310-0.561+60.871
TTM60.310-1.388+61.698
YOY87.565-2.175+89.740
5Y78.586-1.249+79.835
10Y67.615-1.895+69.510
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Idexx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 31.40 means the investor is paying $31.40 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of IDEXX Laboratories Inc:

  • The EOD is 27.187. Based on the equity, the company is expensive. -2
  • The MRQ is 31.398. Based on the equity, the company is expensive. -2
  • The TTM is 31.398. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD27.187MRQ31.398-4.212
MRQ31.398TTM31.3980.000
TTM31.398YOY56.697-25.298
TTM31.3985Y73.554-42.155
5Y73.55410Y-172.660+246.214
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD27.1872.018+25.169
MRQ31.3982.211+29.187
TTM31.3982.168+29.230
YOY56.6973.014+53.683
5Y73.5543.475+70.079
10Y-172.6604.079-176.739
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of IDEXX Laboratories Inc.

3.1. Institutions holding IDEXX Laboratories Inc

Institutions are holding 92.013% of the shares of IDEXX Laboratories Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc10.90170.128190543074200164.8645
2023-12-31Vanguard Group Inc10.0870.101683776671172071.4189
2023-12-31State Street Corporation4.54760.1023776949148790.3955
2023-12-31AllianceBernstein L.P.3.53720.62752937760-388256-11.6733
2023-12-31Fundsmith LLP3.28576.34072728917-235637-7.9485
2023-12-31BAMCO Inc2.76933.39992300017-36313-1.5543
2023-12-31Geode Capital Management, LLC2.53360.12192104258401191.9436
2023-12-31Franklin Resources Inc1.69270.36491405824284752.0674
2023-12-31Amvescap Plc.1.59730.175213265931096159.0071
2023-12-31Goldman Sachs Group Inc1.47980.06121229074686838126.6677
2023-12-31Blair William & Co1.44632.272120125113060.1088
2024-03-31Brown Advisory Holdings Inc1.42360.85341182330252712.1841
2023-12-31Morgan Stanley - Brokerage Accounts1.31840.05361094980304662.862
2023-12-31Capital World Investors1.23130.1011022678113511.1224
2023-12-31NORGES BANK1.11110.08959227819815211.9026
2023-12-31Northern Trust Corp1.03860.0867862595-56596-6.1572
2023-12-31JPMorgan Chase & Co1.0360.0459860479592057.3889
2023-12-31FUNDSMITH INVESTMENT SERVICES LTD.0.98566.5624818619-170973-17.2771
2023-12-31Legal & General Group PLC0.94780.112178719811515917.1358
2023-12-31Principal Financial Group Inc0.94080.2765781368-34495-4.228
Total 53.911421.876144775645+835789+1.9%

3.2. Funds holding IDEXX Laboratories Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Vanguard Total Stock Mkt Idx Inv3.14910.0882261545790070.3456
2024-03-31Vanguard Institutional 500 Index Trust2.52030.10162093245180610.8703
2024-03-31Invesco QQQ Trust1.87520.3244155744900
2024-03-31SPDR® S&P 500 ETF Trust1.20740.10151002762-7742-0.7662
2024-02-29Fidelity 500 Index1.20.1113996620100291.0165
2023-09-30Fundsmith Equity I Acc1.14924.8131954446-30186-3.0657
2024-03-31Vanguard Mid Cap Index Institutional1.08680.2924902620-25320-2.7286
2024-02-29AllianceBernstein US L/C Growth Eqty MF1.06171.8722881768208112.4172
2023-12-31Capital Group New Perspective Comp1.04710.38186964300
2024-03-28iShares Core S&P 500 ETF1.03620.101586064062720.7341
2024-02-29AB Large Cap Growth A1.0141.8351842169381914.7503
2024-03-31Vanguard Growth Index Investor0.95050.1882789428175232.2701
2024-03-31Baron Partners Retail0.84286.2471700000-100000-12.5
2024-03-31Franklin DynaTech Fund A0.78261.430165000000
2024-03-31Franklin Innovation Composite0.78261.4301650000-50000-7.1429
2024-03-31BlackRock Mid-Cap Growth Equity Instl0.75122.664462386800
2024-03-31Health Care Select Sector SPDR® ETF0.75020.8188623083-3136-0.5008
2024-03-31Baron Mid Cap Growth Strategy0.66066.486548630-67000-10.8832
2024-03-31Baron Asset Retail0.66066.4875548630-67000-10.8832
2024-03-31Vanguard Institutional Index I0.65740.1014546005-1418-0.259
Total 23.185535.875919256463-231908-1.2%

3.3. Insider Transactions

Insiders are holding 0.927% of the shares of IDEXX Laboratories Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-08George FennellSELL8198573.87
2024-02-07Brian P MckeonSELL23326570.01
2024-02-07Jonathan Jay MazelskySELL12000572.61
2023-12-07James F PolewaczykSELL11636521.79
2023-12-04Jonathan Jay MazelskySELL7128513.05
2023-08-31Jonathan Jay MazelskySELL13424512.01
2023-08-29James F PolewaczykSELL22909510.56
2023-08-03Michael LaneSELL16027510
2023-05-18Jonathan W AyersSELL10000489.23
2023-05-05Michael LaneSELL1000484
2023-05-04Sophie V VandebroekSELL2187469.02

4. Summary

4.1. Key Performance Indicators

The key performance indicators of IDEXX Laboratories Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--10.48210.4820%-0.775+107%3.556+195%1.288+714%
Book Value Per Share--17.67817.6780%7.195+146%8.434+110%4.054+336%
Current Ratio--1.5711.5710%0.891+76%1.295+21%1.108+42%
Debt To Asset Ratio--0.5450.5450%0.778-30%0.733-26%0.875-38%
Debt To Equity Ratio--1.1961.1960%3.512-66%3.839-69%2.997-60%
Dividend Per Share----0%-0%0.308-100%0.154-100%
Eps--10.06310.0630%8.027+25%7.658+31%5.177+94%
Free Cash Flow Per Share--9.2039.2030%4.659+98%6.182+49%4.348+112%
Free Cash Flow To Equity Per Share--3.9403.9400%0.274+1336%1.415+179%0.612+544%
Gross Profit Margin--0.3300.3300%0.228+45%0.236+40%-0.074+123%
Intrinsic Value_10Y_max--114.746--------
Intrinsic Value_10Y_min--60.287--------
Intrinsic Value_1Y_max--8.042--------
Intrinsic Value_1Y_min--4.823--------
Intrinsic Value_3Y_max--26.798--------
Intrinsic Value_3Y_min--15.633--------
Intrinsic Value_5Y_max--48.729--------
Intrinsic Value_5Y_min--27.610--------
Market Cap39915798537.600-17%46611988900.00046611988900.0000%34513416000.000+35%40867834524.000+14%26734056608.000+74%
Net Profit Margin--0.2310.2310%0.202+14%0.211+9%0.173+34%
Operating Margin--0.3000.3000%0.267+12%0.269+12%0.230+31%
Operating Ratio--0.7000.7000%0.733-4%0.731-4%0.766-9%
Pb Ratio27.187-15%31.39831.3980%56.697-45%73.554-57%-172.660+650%
Pe Ratio47.761-15%55.15955.1590%50.823+9%62.095-11%57.364-4%
Price Per Share480.600-15%555.050555.0500%407.960+36%476.494+16%306.334+81%
Price To Free Cash Flow Ratio52.220-15%60.31060.3100%87.565-31%78.586-23%67.615-11%
Price To Total Gains Ratio45.849-15%52.95252.9520%-526.618+1095%51.559+3%42.210+25%
Quick Ratio--0.9580.9580%0.415+131%0.754+27%0.758+26%
Return On Assets--0.2590.2590%0.247+5%0.2600%0.210+23%
Return On Equity--0.5690.5690%1.116-49%1.219-53%0.764-26%
Total Gains Per Share--10.48210.4820%-0.775+107%3.865+171%1.442+627%
Usd Book Value--1484530000.0001484530000.0000%608737000.000+144%718775800.000+107%345618500.000+330%
Usd Book Value Change Per Share--10.48210.4820%-0.775+107%3.556+195%1.288+714%
Usd Book Value Per Share--17.67817.6780%7.195+146%8.434+110%4.054+336%
Usd Dividend Per Share----0%-0%0.308-100%0.154-100%
Usd Eps--10.06310.0630%8.027+25%7.658+31%5.177+94%
Usd Free Cash Flow--772879000.000772879000.0000%394146000.000+96%529478600.000+46%379948800.000+103%
Usd Free Cash Flow Per Share--9.2039.2030%4.659+98%6.182+49%4.348+112%
Usd Free Cash Flow To Equity Per Share--3.9403.9400%0.274+1336%1.415+179%0.612+544%
Usd Market Cap39915798537.600-17%46611988900.00046611988900.0000%34513416000.000+35%40867834524.000+14%26734056608.000+74%
Usd Price Per Share480.600-15%555.050555.0500%407.960+36%476.494+16%306.334+81%
Usd Profit--845042000.000845042000.0000%679089000.000+24%655694400.000+29%451467600.000+87%
Usd Revenue--3660953000.0003660953000.0000%3367324000.000+9%3071440000.000+19%2440262200.000+50%
Usd Total Gains Per Share--10.48210.4820%-0.775+107%3.865+171%1.442+627%
 EOD+4 -4MRQTTM+0 -0YOY+31 -35Y+31 -510Y+31 -5

4.2. Fundamental Score

Let's check the fundamental score of IDEXX Laboratories Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1547.761
Price to Book Ratio (EOD)Between0-127.187
Net Profit Margin (MRQ)Greater than00.231
Operating Margin (MRQ)Greater than00.300
Quick Ratio (MRQ)Greater than10.958
Current Ratio (MRQ)Greater than11.571
Debt to Asset Ratio (MRQ)Less than10.545
Debt to Equity Ratio (MRQ)Less than11.196
Return on Equity (MRQ)Greater than0.150.569
Return on Assets (MRQ)Greater than0.050.259
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of IDEXX Laboratories Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.789
Ma 20Greater thanMa 50491.576
Ma 50Greater thanMa 100524.020
Ma 100Greater thanMa 200534.746
OpenGreater thanClose485.820
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets3,259,925
Total Liabilities1,775,395
Total Stockholder Equity1,484,530
 As reported
Total Liabilities 1,775,395
Total Stockholder Equity+ 1,484,530
Total Assets = 3,259,925

Assets

Total Assets3,259,925
Total Current Assets1,495,254
Long-term Assets1,764,671
Total Current Assets
Cash And Cash Equivalents 453,932
Net Receivables 457,445
Inventory 380,282
Other Current Assets 203,595
Total Current Assets  (as reported)1,495,254
Total Current Assets  (calculated)1,495,254
+/-0
Long-term Assets
Property Plant Equipment 702,177
Goodwill 365,961
Long Term Investments 56,193
Intangible Assets 84,500
Long-term Assets Other 448,476
Long-term Assets  (as reported)1,764,671
Long-term Assets  (calculated)1,657,307
+/- 107,364

Liabilities & Shareholders' Equity

Total Current Liabilities951,547
Long-term Liabilities823,848
Total Stockholder Equity1,484,530
Total Current Liabilities
Short-term Debt 324,997
Short Long Term Debt 324,997
Accounts payable 110,643
Other Current Liabilities 478,712
Total Current Liabilities  (as reported)951,547
Total Current Liabilities  (calculated)1,239,349
+/- 287,802
Long-term Liabilities
Long term Debt 622,883
Capital Lease Obligations 119,473
Long-term Liabilities  (as reported)823,848
Long-term Liabilities  (calculated)742,356
+/- 81,492
Total Stockholder Equity
Common Stock10,751
Retained Earnings 4,444,571
Accumulated Other Comprehensive Income -71,206
Other Stockholders Equity -2,899,586
Total Stockholder Equity (as reported)1,484,530
Total Stockholder Equity (calculated)1,484,530
+/-0
Other
Capital Stock10,751
Cash and Short Term Investments 453,932
Common Stock Shares Outstanding 83,978
Current Deferred Revenue37,195
Liabilities and Stockholders Equity 3,259,925
Net Debt 493,948
Net Invested Capital 2,432,410
Net Working Capital 543,707
Property Plant and Equipment Gross 1,602,493
Short Long Term Debt Total 947,880



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-311992-12-311991-12-31
> Total Assets 
38,100
79,700
98,000
121,700
312,500
373,900
377,000
390,500
360,200
335,796
373,107
416,652
521,875
514,237
490,676
559,560
702,179
765,437
808,527
897,144
1,030,814
1,103,602
1,230,516
1,384,211
1,474,993
1,530,704
1,713,416
1,537,349
1,832,475
2,294,561
2,437,203
2,746,765
3,259,925
3,259,9252,746,7652,437,2032,294,5611,832,4751,537,3491,713,4161,530,7041,474,9931,384,2111,230,5161,103,6021,030,814897,144808,527765,437702,179559,560490,676514,237521,875416,652373,107335,796360,200390,500377,000373,900312,500121,70098,00079,70038,100
   > Total Current Assets 
26,400
57,400
76,800
98,500
262,000
301,700
274,200
263,300
232,400
215,830
235,576
289,120
370,589
301,592
299,245
302,263
305,663
355,890
376,338
460,591
524,227
569,537
652,706
759,398
821,634
845,584
971,985
654,172
679,639
1,062,738
955,655
1,101,477
1,495,254
1,495,2541,101,477955,6551,062,738679,639654,172971,985845,584821,634759,398652,706569,537524,227460,591376,338355,890305,663302,263299,245301,592370,589289,120235,576215,830232,400263,300274,200301,700262,00098,50076,80057,40026,400
       Cash And Cash Equivalents 
9,300
17,200
18,900
25,200
149,300
127,700
107,000
109,100
58,600
46,007
66,666
113,788
186,717
47,156
67,151
61,666
60,360
78,868
106,728
156,915
183,895
223,986
279,058
322,536
128,994
154,901
187,675
123,794
90,326
383,928
144,454
112,546
453,932
453,932112,546144,454383,92890,326123,794187,675154,901128,994322,536279,058223,986183,895156,915106,72878,86860,36061,66667,15147,156186,717113,78866,66646,00758,600109,100107,000127,700149,30025,20018,90017,2009,300
       Short-term Investments 
0
0
0
0
0
0
0
0
0
29,196
12,893
33,403
33,988
90,116
65,580
35,000
0
0
0
0
0
0
0
0
213,591
236,949
284,255
0
0
0
0
0
0
000000284,255236,949213,5910000000035,00065,58090,11633,98833,40312,89329,196000000000
       Net Receivables 
10,500
11,900
21,400
25,800
47,300
66,600
47,300
47,900
58,400
57,266
50,772
45,689
53,976
65,639
71,688
81,389
108,384
111,498
115,107
120,080
141,275
138,324
158,038
152,380
188,318
204,494
234,597
248,855
269,312
331,429
368,348
400,619
457,445
457,445400,619368,348331,429269,312248,855234,597204,494188,318152,380158,038138,324141,275120,080115,107111,498108,38481,38971,68865,63953,97645,68950,77257,26658,40047,90047,30066,60047,30025,80021,40011,90010,500
       Inventory 
5,100
12,800
14,600
20,800
28,200
48,400
60,200
55,400
47,500
65,935
86,194
75,086
75,333
76,424
69,369
95,996
98,804
115,926
110,425
127,885
133,099
140,946
133,427
160,342
188,833
158,034
164,318
173,303
195,019
209,873
269,030
367,823
380,282
380,282367,823269,030209,873195,019173,303164,318158,034188,833160,342133,427140,946133,099127,885110,425115,92698,80495,99669,36976,42475,33375,08686,19465,93547,50055,40060,20048,40028,20020,80014,60012,8005,100
       Other Current Assets 
1,500
15,500
21,900
26,700
37,200
59,000
59,700
50,900
67,900
17,426
4,812
6,267
6,800
8,797
11,679
11,328
14,509
49,598
44,078
55,711
65,958
66,281
82,183
124,140
101,898
91,206
101,140
108,220
124,982
137,508
173,823
220,489
203,595
203,595220,489173,823137,508124,982108,220101,14091,206101,898124,14082,18366,28165,95855,71144,07849,59814,50911,32811,6798,7976,8006,2674,81217,42667,90050,90059,70059,00037,20026,70021,90015,5001,500
   > Long-term Assets 
11,700
22,300
21,200
23,200
50,500
72,200
102,800
127,200
127,800
119,966
137,531
127,532
151,286
212,645
191,431
257,297
396,516
409,547
432,189
436,553
506,587
534,065
577,810
624,813
653,359
685,120
741,431
883,177
1,152,836
1,231,823
1,481,548
1,645,288
1,764,671
1,764,6711,645,2881,481,5481,231,8231,152,836883,177741,431685,120653,359624,813577,810534,065506,587436,553432,189409,547396,516257,297191,431212,645151,286127,532137,531119,966127,800127,200102,80072,20050,50023,20021,20022,30011,700
       Property Plant Equipment 
11,000
11,700
12,000
13,400
25,500
36,400
41,000
41,500
39,600
45,661
49,215
49,455
45,224
62,630
65,697
99,628
141,852
189,646
199,946
201,725
216,777
245,177
281,214
303,587
333,026
357,422
379,096
437,270
533,845
555,167
587,667
649,474
702,177
702,177649,474587,667555,167533,845437,270379,096357,422333,026303,587281,214245,177216,777201,725199,946189,646141,85299,62865,69762,63045,22449,45549,21545,66139,60041,50041,00036,40025,50013,40012,00011,70011,000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
52,321
54,994
92,937
88,127
104,826
236,414
138,768
148,705
149,112
172,610
174,994
180,521
184,450
178,934
178,228
199,873
214,489
239,724
243,347
359,345
361,795
365,961
365,961361,795359,345243,347239,724214,489199,873178,228178,934184,450180,521174,994172,610149,112148,705138,768236,414104,82688,12792,93754,99452,32100000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,978
9,949
10,894
13,657
12,065
13,348
55,500
56,193
56,19355,50013,34812,06513,65710,8949,94910,9780000000000000000000000000
       Intangible Assets 
0
10,300
8,900
8,200
0
0
0
0
0
0
0
56,157
61,766
124,494
118,746
43,353
236,414
68,327
63,907
55,752
69,209
62,833
58,844
65,122
55,909
46,155
43,846
41,825
58,468
52,543
99,035
97,672
84,500
84,50097,67299,03552,54358,46841,82543,84646,15555,90965,12258,84462,83369,20955,75263,90768,327236,41443,353118,746124,49461,76656,15700000008,2008,90010,3000
       Long-term Assets Other 
700
300
300
1,600
25,000
35,800
61,800
85,700
88,200
74,305
88,316
-8,539
-4,561
-7,626
6,988
6,237
11,606
219,901
232,243
234,828
289,810
13,023
10,930
23,200
33,496
53,050
100,969
170,218
299,042
337,152
397,369
425,632
448,476
448,476425,632397,369337,152299,042170,218100,96953,05033,49623,20010,93013,023289,810234,828232,243219,90111,6066,2376,988-7,626-4,561-8,53988,31674,30588,20085,70061,80035,80025,0001,600300300700
> Total Liabilities 
6,600
9,300
14,400
21,900
33,400
51,200
74,300
82,700
75,900
74,049
71,377
75,679
108,583
116,577
121,366
149,699
263,856
327,243
293,948
322,863
491,221
467,345
712,302
1,266,622
1,558,988
1,638,917
1,767,258
1,546,582
1,654,650
1,661,766
1,747,211
2,138,028
1,775,395
1,775,3952,138,0281,747,2111,661,7661,654,6501,546,5821,767,2581,638,9171,558,9881,266,622712,302467,345491,221322,863293,948327,243263,856149,699121,366116,577108,58375,67971,37774,04975,90082,70074,30051,20033,40021,90014,4009,3006,600
   > Total Current Liabilities 
6,600
9,400
14,300
22,000
33,400
51,100
74,300
78,500
75,500
74,049
71,377
75,679
100,736
99,952
106,566
124,743
223,392
295,292
256,305
285,112
436,879
406,333
478,353
820,906
856,761
934,568
1,004,567
770,444
725,337
582,761
763,579
1,235,803
951,547
951,5471,235,803763,579582,761725,337770,4441,004,567934,568856,761820,906478,353406,333436,879285,112256,305295,292223,392124,743106,56699,952100,73675,67971,37774,04975,50078,50074,30051,10033,40022,00014,3009,4006,600
       Short-term Debt 
0
0
0
0
1,700
3,000
4,100
5,200
3,300
8,472
8,380
973
494
1,291
551
678
72,956
151,385
119,603
129,862
243,917
213,107
278,035
549,000
573,000
611,000
655,000
398,937
288,765
49,988
148,496
653,982
324,997
324,997653,982148,49649,988288,765398,937655,000611,000573,000549,000278,035213,107243,917129,862119,603151,38572,9566785511,2914949738,3808,4723,3005,2004,1003,0001,7000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
549,000
573,000
611,000
655,000
398,937
288,765
49,988
148,496
653,982
324,997
324,997653,982148,49649,988288,765398,937655,000611,000573,000549,00000000000000000000000000
       Accounts payable 
3,100
4,300
7,200
9,200
10,800
18,700
12,500
26,800
19,600
13,714
10,887
9,427
19,160
14,723
19,842
24,374
32,510
28,006
19,133
22,669
36,551
35,288
29,941
44,743
52,648
60,057
66,968
69,534
72,172
74,558
116,140
110,221
110,643
110,643110,221116,14074,55872,17269,53466,96860,05752,64844,74329,94135,28836,55122,66919,13328,00632,51024,37419,84214,72319,1609,42710,88713,71419,60026,80012,50018,70010,8009,2007,2004,3003,100
       Other Current Liabilities 
3,500
5,100
7,100
12,800
20,900
29,400
57,700
46,500
52,600
51,863
38,890
51,710
72,807
73,785
78,208
90,715
107,248
104,616
104,959
118,598
141,383
137,746
148,919
195,351
205,530
236,131
253,418
260,683
322,938
415,648
458,909
433,662
478,712
478,712433,662458,909415,648322,938260,683253,418236,131205,530195,351148,919137,746141,383118,598104,959104,616107,24890,71578,20873,78572,80751,71038,89051,86352,60046,50057,70029,40020,90012,8007,1005,1003,500
   > Long-term Liabilities 
0
-100
100
-100
0
100
1,400
4,200
400
0
0
6,200
7,847
16,625
14,800
24,956
40,464
31,951
37,643
37,751
54,342
61,012
233,949
445,716
702,227
704,349
762,691
776,138
929,313
1,079,005
983,632
902,225
823,848
823,848902,225983,6321,079,005929,313776,138762,691704,349702,227445,716233,94961,01254,34237,75137,64331,95140,46424,95614,80016,6257,8476,200004004,2001,4001000-100100-1000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,418
2,501
1,394
150,359
350,000
597,085
593,110
606,075
601,348
698,910
858,492
775,205
694,387
0
0694,387775,205858,492698,910601,348606,075593,110597,085350,000150,3591,3942,5013,4180000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
6,825
7,264
8,774
11,355
20,040
14,924
15,079
15,672
28,553
36,590
49,642
54,028
105,142
111,239
156,616
174,790
162,828
220,513
208,427
106,594
0
0106,594208,427220,513162,828174,790156,616111,239105,14254,02849,64236,59028,55315,67215,07914,92420,04011,3558,7747,2646,825000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,288
34,111
35,720
52,375
63,353
76,444
72,302
60,898
29,267
33,024
11,707
8,935
8,150
0
08,1508,93511,70733,02429,26760,89872,30276,44463,35352,37535,72034,11123,2880000000000000000000
> Total Stockholder Equity
31,500
70,400
83,600
99,800
279,100
322,700
302,700
307,800
284,300
261,747
301,730
340,973
413,292
397,660
369,010
409,861
438,323
438,194
514,569
574,235
539,579
636,223
518,186
117,516
-84,125
-108,352
-54,106
-9,513
177,473
632,088
689,992
608,737
1,484,530
1,484,530608,737689,992632,088177,473-9,513-54,106-108,352-84,125117,516518,186636,223539,579574,235514,569438,194438,323409,861369,010397,660413,292340,973301,730261,747284,300307,800302,700322,700279,10099,80083,60070,40031,500
   Common Stock
0
0
0
0
0
0
0
0
4,000
4,025
4,135
4,233
4,439
4,522
4,594
4,662
9,450
9,539
9,633
9,797
9,923
10,016
10,119
10,195
10,258
10,334
10,428
10,509
10,571
10,646
10,688
10,719
10,751
10,75110,71910,68810,64610,57110,50910,42810,33410,25810,19510,11910,0169,9239,7979,6339,5399,4504,6624,5944,5224,4394,2334,1354,0254,00000000000
   Retained Earnings 
-4,500
400
10,400
23,700
45,200
67,400
46,300
31,000
63,600
100,251
137,871
183,260
240,350
318,682
396,936
490,614
585,862
702,031
824,256
965,540
1,127,326
1,305,593
1,493,393
1,675,299
318,356
540,401
803,545
1,167,928
1,595,648
2,175,595
2,920,440
3,599,529
4,444,571
4,444,5713,599,5292,920,4402,175,5951,595,6481,167,928803,545540,401318,3561,675,2991,493,3931,305,5931,127,326965,540824,256702,031585,862490,614396,936318,682240,350183,260137,871100,25163,60031,00046,30067,40045,20023,70010,400400-4,500
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
641,645
702,575
757,214
825,320
888,293
940,534
1,011,895
1,073,931
1,138,216
1,213,517
1,294,849
1,377,320
1,463,215
0
01,463,2151,377,3201,294,8491,213,5171,138,2161,073,9311,011,895940,534888,293825,320757,214702,575641,6450000000000000000000
   Treasury Stock00-3,570,691-2,799,890-2,600,543-2,288,899-1,911,528-1,633,443-1,316,417-2,453,266-1,829,378-1,457,184-1,320,376-1,060,647-914,759-830,390-696,668-577,826-472,096-348,327-219,449-178,357-147,465-134,479000000000
   Other Stockholders Equity 
36,000
70,000
73,200
76,100
233,900
278,200
286,800
317,800
220,200
162,435
166,418
155,991
163,800
62,490
-34,702
-97,833
-181,895
-279,051
-329,661
-414,569
-613,113
-695,340
-998,948
-1,559,907
-370,474
-616,034
-831,609
-1,146,159
-1,382,564
-1,500,538
-2,187,652
-2,923,715
-2,899,586
-2,899,586-2,923,715-2,187,652-1,500,538-1,382,564-1,146,159-831,609-616,034-370,474-1,559,907-998,948-695,340-613,113-414,569-329,661-279,051-181,895-97,833-34,70262,490163,800155,991166,418162,435220,200317,800286,800278,200233,90076,10073,20070,00036,000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,660,953
Cost of Revenue-1,470,983
Gross Profit2,189,9702,189,970
 
Operating Income (+$)
Gross Profit2,189,970
Operating Expense-1,092,842
Operating Income1,097,1281,097,128
 
Operating Expense (+$)
Research Development190,951
Selling General Administrative335,825
Selling And Marketing Expenses566,066
Operating Expense1,092,8421,092,842
 
Net Interest Income (+$)
Interest Income2,233
Interest Expense-35,952
Other Finance Cost-9,911
Net Interest Income-43,630
 
Pretax Income (+$)
Operating Income1,097,128
Net Interest Income-43,630
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,061,1761,133,080
EBIT - interestExpense = 1,061,176
1,061,176
880,994
Interest Expense35,952
Earnings Before Interest and Taxes (EBIT)1,097,1281,097,128
Earnings Before Interest and Taxes (EBITDA)1,097,128
 
After tax Income (+$)
Income Before Tax1,061,176
Tax Provision-211,995
Net Income From Continuing Ops822,728849,181
Net Income845,042
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,563,825
Total Other Income/Expenses Net-35,95243,630
 

Technical Analysis of Idexx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Idexx. The general trend of Idexx is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Idexx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of IDEXX Laboratories Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 507.61 < 510.02 < 543.33.

The bearish price targets are: 458.97 > 456.78 > 435.83.

Tweet this
IDEXX Laboratories Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of IDEXX Laboratories Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

IDEXX Laboratories Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of IDEXX Laboratories Inc. The current macd is -11.37889365.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Idexx price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Idexx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Idexx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
IDEXX Laboratories Inc Daily Moving Average Convergence/Divergence (MACD) ChartIDEXX Laboratories Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of IDEXX Laboratories Inc. The current adx is 32.20.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Idexx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
IDEXX Laboratories Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of IDEXX Laboratories Inc. The current sar is 507.02.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
IDEXX Laboratories Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of IDEXX Laboratories Inc. The current rsi is 39.79. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
IDEXX Laboratories Inc Daily Relative Strength Index (RSI) ChartIDEXX Laboratories Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of IDEXX Laboratories Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Idexx price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
IDEXX Laboratories Inc Daily Stochastic Oscillator ChartIDEXX Laboratories Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of IDEXX Laboratories Inc. The current cci is -48.5060026.

IDEXX Laboratories Inc Daily Commodity Channel Index (CCI) ChartIDEXX Laboratories Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of IDEXX Laboratories Inc. The current cmo is -17.16858109.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
IDEXX Laboratories Inc Daily Chande Momentum Oscillator (CMO) ChartIDEXX Laboratories Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of IDEXX Laboratories Inc. The current willr is -60.32.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Idexx is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
IDEXX Laboratories Inc Daily Williams %R ChartIDEXX Laboratories Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of IDEXX Laboratories Inc.

IDEXX Laboratories Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of IDEXX Laboratories Inc. The current atr is 13.45.

IDEXX Laboratories Inc Daily Average True Range (ATR) ChartIDEXX Laboratories Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of IDEXX Laboratories Inc. The current obv is 4,235,187.

IDEXX Laboratories Inc Daily On-Balance Volume (OBV) ChartIDEXX Laboratories Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of IDEXX Laboratories Inc. The current mfi is 45.73.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
IDEXX Laboratories Inc Daily Money Flow Index (MFI) ChartIDEXX Laboratories Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for IDEXX Laboratories Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-03STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

IDEXX Laboratories Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of IDEXX Laboratories Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.789
Ma 20Greater thanMa 50491.576
Ma 50Greater thanMa 100524.020
Ma 100Greater thanMa 200534.746
OpenGreater thanClose485.820
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Idexx with someone you think should read this too:
  • Are you bullish or bearish on Idexx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Idexx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about IDEXX Laboratories Inc

I send you an email if I find something interesting about IDEXX Laboratories Inc.


Comments

How you think about this?

Leave a comment

Stay informed about IDEXX Laboratories Inc.

Receive notifications about IDEXX Laboratories Inc in your mailbox!